Fox Chase Cancer Center News

October 25, 2022

Certain Head and Neck Cancer Survivors at Greater Risk for Long-Term Gastrostomy Tube Use

PHILADELPHIA (October 25, 2022)—A small subset of patients who undergo treatment for head and neck cancer may require a gastrostomy tube many years into survivorship, according to a study presented today by researchers from Fox Chase Cancer Center at the annual meeting of the American Society for Radiation Oncology.

VIEW STORY

October 23, 2022

Higher Radiation Dose May Sometimes Balance Out Delayed Treatment Sessions, Study Finds

PHILADELPHIA (October 23, 2022)—It’s common for lung cancer patients receiving radiation therapy to miss a few treatment days. But how many missed days is too many? And can providers make up for the delayed treatments by increasing the radiation dose?

VIEW STORY

October 22, 2022

Fox Chase’s Dr. Jessica Karen Wong to Discuss Management of Metastatic Prostate Cancer at ESMO Education Conference

PHILADELPHIA (October 21, 2022)—Jessica Karen Wong, MD, MEng, of Fox Chase Cancer Center will discuss new trends in the management of oligometastatic prostate cancer, including the increased use of localized treatments such as radiation that are increasing local control and improving outcomes.

VIEW STORY

October 21, 2022

Fox Chase Cancer Center’s Dr. Shelly Hayes Receives Earth Angel Award During 5th Annual Pine2Pink Event

PHILADELPHIA (October 21, 2022)—Shelly Hayes, MD, director of Fox Chase Cancer Center Buckingham and associate professor in the Department of Radiation Oncology, was recently presented with an inaugural Earth Angel Award during the 5th Annual Pine2Pink event in Doylestown.

VIEW STORY

October 21, 2022

Fox Chase Cancer Center’s Dr. Andrea Porpiglia Inducted Into Philadelphia Academy of Surgery

PHILADELPHIA (October 21, 2022)—Fox Chase Cancer Center’s Andrea Porpiglia, MD, MSc, FACS, assistant professor in the Department of Surgical Oncology, was recently inducted as a fellow into the Philadelphia Academy of Surgery.

VIEW STORY

October 20, 2022

Fox Chase Providers Receive 2021 JADPRO Article of the Year Award for Review on Managing Adverse Events in Immunotherapy

PHILADELPHIA (October 20, 2022)—A team of advanced practice providers in the Department of Hematology/Oncology at Fox Chase Cancer Center have received the 2021 Article of the Year Award from the Journal of the Advanced Practitioner in Oncology (JADPRO). This award is given to one article each year that demonstrates an exceptional contribution to the body of literature for oncology advanced practice.

VIEW STORY

October 18, 2022

Review Paper Distills Current Research on BTKi Drugs for Treatment of Lymphoma

PHILADELPHIA (October 18, 2022)—The development of a family of drugs known as Bruton tyrosine kinase inhibitors (BTKi) was a huge step forward in treating chronic lymphocytic leukemia and non-Hodgkin lymphoma.

VIEW STORY

October 17, 2022

Fox Chase Receives $6 Million Grant as Founding Member of New National Cancer Institute Prevention Initiative

PHILADELPHIA (October 17, 2022)—Fox Chase Cancer Center was recently awarded a grant for $6 million over the course of five years to develop a new Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT). The new National Cancer Institute (NCI) program was created to establish a pipeline for the discovery of new cancer-prevention agents.

VIEW STORY

Primary tabs

Fox Chase Cancer Center News

Share